Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Shanghai Starts Drug Quality Authorization System

This article was originally published in PharmAsia News

Executive Summary

Shanghai has officially implemented a drug quality authorization system since June (PharmAsia News, Apr. 13, 2009), starting with pharmaceutical companies producing high-risk items such as blood products, vaccines, injections and controlled drugs. The city's FDA also encourages other firms to voluntarily adopt the system. Currently, there is a shortage of qualified personnel for authorizing drug quality. Shanghai FDA will collaborate with the Shanghai Association for Quality's Medical Commission and Shanghai Licensed Pharmacist Association to promote continuing education for professionals. In addition, China's State FDA is intensifying the formulation of new GMP standards, which is likely to include the drug quality authorization system. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts